Business Description
PYC Therapeutics Ltd
ISIN : AU000000PYC7
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 46.72 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -32.6 | |||||
3-Year EPS without NRI Growth Rate | -32.6 | |||||
3-Year FCF Growth Rate | -58.7 | |||||
3-Year Book Growth Rate | -3.9 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 10 | |||||
12-1 Month Momentum % | 34.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.99 | |||||
Quick Ratio | 3.99 | |||||
Cash Ratio | 2.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | -3.65 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -81.02 | |||||
ROA % | -59.81 | |||||
ROIC % | -447.75 | |||||
ROC (Joel Greenblatt) % | -1380.59 | |||||
ROCE % | -77.71 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 12.5 | |||||
Price-to-Tangible-Book | 8.9 | |||||
EV-to-EBIT | -20.43 | |||||
EV-to-EBITDA | -20.85 | |||||
EV-to-FCF | -22.08 | |||||
Price-to-Net-Current-Asset-Value | 8.9 | |||||
Earnings Yield (Greenblatt) % | -4.89 | |||||
FCF Yield % | -4.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PYC Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 51.1 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0.002071 | ||
20-Day SMA (€) | 0 | ||
12-1 Month Momentum % | 34.09 | ||
52-Week Range (€) | 0.06662 - 0.12 | ||
Shares Outstanding (Mil) | 3,180.93 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PYC Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PYC Therapeutics Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
PYC Therapeutics Ltd Frequently Asked Questions
What is PYC Therapeutics Ltd(FRA:PH7)'s stock price today?
When is next earnings date of PYC Therapeutics Ltd(FRA:PH7)?
Does PYC Therapeutics Ltd(FRA:PH7) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |